BofA lowered the firm’s price target on RXO Inc. (RXO) to $16 from $18 and keeps a Neutral rating on the shares after the company reported Q3 results and issued a Q4 EBITDA target significantly below BofA and the Street’s forecast. Following the report and guidance, the firm lowered its FY26 and FY27 EPS estimates by 61% and 39%, respectively.
TipRanks Cyber Monday Sale
- Claim 60% off TipRanks Premium for data-backed insights and research tools you need to invest with confidence.
- Subscribe to TipRanks' Smart Investor Picks and see our data in action through our high-performing model portfolio - now also 60% off
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on RXO: